Antineoplastic Drug-Induced Cardiotoxicity: A Redox PerspectiveGilda Varricchi, Carlo G. Tocchetti, Paolo Spallarossa et al.|Frontiers in Physiology|2018Cited by 154
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational OverviewCarlo G. Tocchetti, Giuseppe Mercuro, Paolo Spallarossa et al.|Antioxidants and Redox Signaling|2017Cited by 122
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogensChristian Cadeddu Dessalvi, Giuseppe Mercuro, Rosalinda Madonna et al.|Heart Failure Reviews|2019Cited by 55
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and CardioprotectionRosalinda Madonna, Giuseppe Mercuro, Martino Deidda et al.|Heart Failure Reviews|2015Cited by 45